Breaking News

VWR Acquires United Biochemicals

Expands life sciences portfolio

VWR International has acquired United Biochemicals Inc., a manufacturer and supplier of high purity buffers and biochemicals for research, development and manufacturing processes to pharma, biopharma, cell culture media, and medical diagnostic industries. Financial terms were not disclosed.
 
“United Biochemicals is a strong compliment to VWR’s growing life sciences portfolio as VWR continues to make strategic investment into our business,” said Manuel Brocke-Benz, president and chief executive officer of VWR. “United Biochemicals’ manufacturing expertise, combined with VWR’s existing platform of chemical manufacturing assets, enhances our current offering to our biotech and pharmaceutical customers and strengthens our position in the industry.”
 
“We are excited to join a trusted, global brand like VWR,” said Fayyaz Hussain, president of United Biochemicals.  “This acquisition will allow United Biochemicals to leverage VWR’s global sales and marketing organization to grow our business.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters